Profile | GDS5420 / 214075_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 351.87 | 61 |
GSM1296119 | B_lesional_pre-dose | 78.88 | 36 |
GSM1296076 | C_lesional_pre-dose | 104.98 | 43 |
GSM1296092 | D_lesional_pre-dose | 200.16 | 54 |
GSM1296103 | E_lesional_pre-dose | 265.62 | 57 |
GSM1296078 | F_lesional_pre-dose | 117.97 | 45 |
GSM1296107 | G_lesional_pre-dose | 80.72 | 36 |
GSM1296109 | H_lesional_pre-dose | 131.78 | 44 |
GSM1296080 | I_lesional_pre-dose | 285.9 | 59 |
GSM1296090 | J_lesional_pre-dose | 200.72 | 54 |
GSM1296074 | K_lesional_pre-dose | 145.27 | 50 |
GSM1296111 | L_lesional_pre-dose | 76.85 | 35 |
GSM1296099 | M_lesional_pre-dose | 160.94 | 49 |
GSM1296086 | O_lesional_pre-dose | 219.67 | 55 |
GSM1296117 | P_lesional_pre-dose | 82.72 | 36 |
GSM1296113 | Q_lesional_pre-dose | 78.36 | 34 |
GSM1296096 | R_lesional_pre-dose | 163.8 | 50 |
GSM1296105 | S_lesional_pre-dose | 186.6 | 50 |
GSM1296098 | T_lesional_pre-dose | 266.54 | 57 |
GSM1296101 | U_lesional_pre-dose | 244.85 | 55 |
GSM1296121 | V_lesional_pre-dose | 82.81 | 37 |
GSM1296088 | W_lesional_pre-dose | 206.06 | 53 |
GSM1296082 | X_lesional_pre-dose | 127.72 | 47 |
GSM1296115 | Y_lesional_pre-dose | 65.43 | 33 |
GSM1296084 | Z_lesional_pre-dose | 385.71 | 63 |
GSM1296072 | B_lesional_day8 | 108.21 | 41 |
GSM1296069 | L_lesional_day8 | 98.47 | 38 |
GSM1296071 | P_lesional_day8 | 102.18 | 39 |
GSM1296070 | Y_lesional_day8 | 78.41 | 35 |
GSM1296073 | V_lesional_day8 | 88.3 | 39 |
GSM1296034 | A_lesional_day15 | 420.52 | 64 |
GSM1296041 | G_lesional_day15 | 66.96 | 33 |
GSM1296035 | R_lesional_day15 | 193.11 | 52 |
GSM1296038 | U_lesional_day15 | 184.39 | 51 |
GSM1296047 | B_lesional_day15 | 83.17 | 36 |
GSM1296039 | E_lesional_day15 | 110.45 | 43 |
GSM1296042 | H_lesional_day15 | 66.34 | 32 |
GSM1296043 | L_lesional_day15 | 82.98 | 35 |
GSM1296037 | M_lesional_day15 | 281 | 57 |
GSM1296046 | P_lesional_day15 | 64.41 | 31 |
GSM1296044 | Q_lesional_day15 | 100.25 | 39 |
GSM1296045 | Y_lesional_day15 | 86.36 | 35 |
GSM1296025 | C_lesional_day15 | 301.84 | 60 |
GSM1296033 | D_lesional_day15 | 369.04 | 62 |
GSM1296027 | I_lesional_day15 | 433.57 | 66 |
GSM1296032 | J_lesional_day15 | 251.05 | 56 |
GSM1296024 | K_lesional_day15 | 221.84 | 55 |
GSM1296031 | W_lesional_day15 | 368.85 | 62 |
GSM1296028 | X_lesional_day15 | 223.82 | 54 |
GSM1296029 | Z_lesional_day15 | 467.92 | 66 |
GSM1296026 | F_lesional_day15 | 252.46 | 57 |
GSM1296030 | O_lesional_day15 | 536.82 | 69 |
GSM1296040 | S_lesional_day15 | 338.14 | 61 |
GSM1296036 | T_lesional_day15 | 249.94 | 55 |
GSM1296048 | V_lesional_day15 | 90.01 | 38 |
GSM1296059 | A_lesional_day43 | 246.22 | 56 |
GSM1296066 | G_lesional_day43 | 60.58 | 31 |
GSM1296060 | R_lesional_day43 | 183.23 | 51 |
GSM1296063 | U_lesional_day43 | 95.79 | 40 |
GSM1296064 | E_lesional_day43 | 86.72 | 40 |
GSM1296067 | H_lesional_day43 | 138.91 | 44 |
GSM1296062 | M_lesional_day43 | 285.81 | 58 |
GSM1296068 | Q_lesional_day43 | 86.38 | 35 |
GSM1296050 | C_lesional_day43 | 137.77 | 46 |
GSM1296057 | D_lesional_day43 | 231.37 | 55 |
GSM1296052 | I_lesional_day43 | 499.86 | 68 |
GSM1296054 | J_lesional_day43 | 306.08 | 59 |
GSM1296049 | K_lesional_day43 | 260.41 | 57 |
GSM1296055 | W_lesional_day43 | 213.93 | 52 |
GSM1296053 | X_lesional_day43 | 340.01 | 61 |
GSM1296058 | Z_lesional_day43 | 293.97 | 59 |
GSM1296051 | F_lesional_day43 | 197.9 | 53 |
GSM1296056 | O_lesional_day43 | 133.43 | 47 |
GSM1296065 | S_lesional_day43 | 86.01 | 39 |
GSM1296061 | T_lesional_day43 | 184.81 | 51 |
GSM1296095 | A_non-lesional_pre-dose | 162.25 | 49 |
GSM1296120 | B_non-lesional_pre-dose | 107.2 | 40 |
GSM1296077 | C_non-lesional_pre-dose | 298.76 | 59 |
GSM1296093 | D_non-lesional_pre-dose | 391 | 63 |
GSM1296104 | E_non-lesional_pre-dose | 84.09 | 39 |
GSM1296079 | F_non-lesional_pre-dose | 267.41 | 58 |
GSM1296108 | G_non-lesional_pre-dose | 122.02 | 43 |
GSM1296110 | H_non-lesional_pre-dose | 130.8 | 43 |
GSM1296081 | I_non-lesional_pre-dose | 272.62 | 58 |
GSM1296091 | J_non-lesional_pre-dose | 274.92 | 58 |
GSM1296075 | K_non-lesional_pre-dose | 164.76 | 51 |
GSM1296112 | L_non-lesional_pre-dose | 107.27 | 39 |
GSM1296100 | M_non-lesional_pre-dose | 233.1 | 54 |
GSM1296087 | O_non-lesional_pre-dose | 487.5 | 68 |
GSM1296118 | P_non-lesional_pre-dose | 110.4 | 40 |
GSM1296114 | Q_non-lesional_pre-dose | 95.23 | 38 |
GSM1296097 | R_non-lesional_pre-dose | 189.38 | 51 |
GSM1296106 | S_non-lesional_pre-dose | 210.31 | 52 |
GSM1296102 | U_non-lesional_pre-dose | 200.88 | 51 |
GSM1296122 | V_non-lesional_pre-dose | 120.05 | 42 |
GSM1296089 | W_non-lesional_pre-dose | 347.77 | 61 |
GSM1296083 | X_non-lesional_pre-dose | 390.19 | 63 |
GSM1296116 | Y_non-lesional_pre-dose | 85.74 | 35 |
GSM1296085 | Z_non-lesional_pre-dose | 376.43 | 63 |